Navigation Links
Reportlinker Adds Radiopharmaceuticals - A US and European Market Analysis
Date:12/8/2009

NEW YORK, Dec. 8 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Radiopharmaceuticals - A US and European Market Analysis

http://www.reportlinker.com/p0164273/Radiopharmaceuticals---A-US-and-European-Market-Analysis.html

The market for radiopharmaceuticals continues to gain momentum with heightened interest in therapeutic efficiency, acceptance and utilization of nuclear medicine equipment, as well as development of newer diagnostic and therapeutic agents. Besides oncology applications, the nuclear medicine field is presently exploring the possibility of extending the scope and functionality of radiopharmaceuticals to other disease applications such as infection imaging, nephrology and neurology applications. Advancements in nuclear medicine technology would represent a key strategic factor in opening up new clinical opportunities for radiopharmaceutical agents.

These and other market data and trends are presented in "Radiopharmaceuticals: A US and European Market Analysis" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.

RADIOPHARMACEUTICALS BMR-1073

CONTENTS

1. METHODOLOGY 1

Study Reliability and Reporting Limitations 1

Disclaimers 2

Quantitative Techniques & Reporting Level 3

2. GLOBAL MARKET OVERVIEW 3

A Quick Primer 3

Key Market Trends 4

Continuous Battle Against Cancer: A Key Driver for Growth 4

Cancer Statistics: A Grim Prognosis 4

Business Case for Radiopharmaceuticals Exemplified 4

Development of Newer Diagnostic Agents to Boost Growth 5

Demographics & New Applications Offer Opportunities On a Platter 5

Recognition of Intrinsic Cost Benefits: Critical to Market

Acceptance 5

Widespread Awareness Among Practitioners & Patients: The Need

of the Hour 6

Expansion of Molecular Imaging Platform is Key to Future Growth 6

Molecular Imaging Agents: A Noteworthy Breakthrough 7

Growing Demand for PET to Drive Up Demand 7

Introduction of SPECT/CT & PET/CT: Double Edged Weapons for

Growth 8

Manufacturers Quick to Take Cue 8

Promising Developments in Therapeutic Radiopharmaceuticals

Underway 9

Targeted Peptides & Alpha Emitters: The New Frontiers of

Therapeutic Radiopharmaceuticals 9

International Collaborations Give a Thumbs Up to Drug

Development 10

Market Challenges 10

High Costs of Drug Development Piques Manufacturers 10

Supply Shortages: A Niggling Cause of Concern 10

Price Sensitivity & Competition from Alternatives Limit

Market Potential 11

Lack of Dosage Standards for Pediatric Patients' Limits

Radiopharmaceutical Efficacy 11

Unfounded Fears of Radiation Exposure Hinder Growth 12

Bottlenecks in Developing Markets 12

Market Share Statistics: In Retrospect 12

3. PRODUCT FACTS 13

A. Diagnostic Radiopharmaceuticals 13

B. Therapeutic Radiopharmaceuticals 14

4. REGIONAL MARKET OVERVIEW 15

i. The United States 15

ii. Europe 34

ii(a). France 37

ii(b). Germany 38

ii(c). Italy 39

ii(d). The United Kingdom 40

ii(e). Spain 41

ii(f). Rest of Europe 42

5. RESEARCH & DEVELOPMENT BREAKTHROUGHS 44

Azaya, Texas University Collaborate for Liposomal Radiation

Therapy 44

Pharmacyclics Reveals Phase 1/2 Study of MGd Antibody Targeted

Radiation Therapy 44

Peregrine Explores Potential of Cotara® for Brain Cancer

Treatment 44

Scientists Develop New Manufacturing Technology For Cancer

Diagnostic Radioisotopes 45

Avid Radiopharmaceuticals Exploits ExpIND to Speed AD Drug

Research 45

Scientists Commend Combination Therapy for Follicular Lymphoma

Patients 46

Missouri University Develops New Cancer Radiotherapy Method 46

AGH Researchers Develop New Radioactive Seed Therapy for Lung

Cancer 47

AnazaoHealth® Obtains US Patent for Novel Radiopharmaceutical

Preparations 47

INMAS Develops Ciprofloxacin Radiolabelling Kit 47

6. CORPORATE DEVELOPMENTS 48

Positron Concludes Dose Shield Acquisition 48

Positron Licenses NuView to Sell Imaging Technologies and Dose

Dispensing Devices 48

Bracco Imaging, Marillion Pharmaceuticals to Develop Novel

Cancer Treatment 48

EUSA Pharma Concludes Cytogen Acquisition 48

AMIC, CRS to Co-Produce Indium-111 49

AMIC, MU Partner to Produce Radioisotopes 49

Bracco, Lantheus to Co-Promote CardioGen-82® 49

Cell Therapeutics Submits sBLA for Use of Zevalin® in First-

Line Therapy 49

Covidien Gets FDA Nod for Generic Myocardial Perfusion Imaging

GE Healthcare Gets FDA Nod For New PET/CT Scanner 50

GE Healthcare, Gamma Medica-Ideas Ink Distribution Deal 50

CIS-US Receives FDA Approval for Generic Choletec® Kit 50

Cellectar Obtains Funds for Clinical Trials 50

Lantheus Medical Completes Phase I Study of Novel PET Imaging

Tracer 50

GE Healthcare, Cardinal Health Partner for Myoview(TM) Imaging Agent 51

Avista Capital Partners Acquires Medical Imaging Unit of

Bristol-Myers 51

Siemens Healthcare Opens Two Radiopharmacies in US 51

Cardinal Health Plans to Offer Services to Support PET

Clinical Trials 51

MEDRAD Associates with PETNET to Ingeniously Deliver FDG 52

Triad Isotopes to Build Four Nuclear Pharmacies 52

AREVA, NCI to Develop Cancer-fighting Radiopharmaceuticals 52

Cardinal Health Expands Manufacturing Capabilities for PET

Imaging Agents 52

Jubilant Completes Draxis Acquisition 53

IBA Plans to Acquire CIS BIO 53

Ion Beam Announces Closure of TAEK Financing 53

IBA Receives Approval for New Radiopharmaceutical Production

Facility in UK 54

Ion Beam Partners with Lantheus to Distribute Neurolite®,

Cardiolite® in Europe 54

EIS Eczacibasi to Acquire 50 Percent Stake in Monrol 54

Siemens to Set up Multiple Radiopharmaceutical Facilities in

India 54

Siemens Plans to Establish Its First Molecular Imaging Centre

in India 55

Bayer and FutureChem Enter Radiolabeling Technology Licensing

Agreement 55

Medrad Mounts Intego(TM) PET Infusion System at UPMC 55

IBA Molecular Announces the Launch of Cyclone ® 18 Twin 56

Immunomedics Announces Pre-Clinical Results for its

Combination Radioimmunotherapy 56

Molecular Insight Develops New Radioiodinated Molecules 56

Immunomedics Develops New Antibody for Radioimmunotherapy 56

Triad Acquires Four Radiopharmaceutical Companies 57

Triad Isotopes Acquires Regional Nuclear Pharmacies 57

Triad Isotopes Merges with Diversified Pharmacy Group 57

Molecular Insight Pharmaceuticals Acquires Radiopharmaceutical

Facility In Texas 57

GE Healthcare to Shelf Production of Products with Short-Lived

Radioisotopes 57

Cell Therapeutics Acquires Zevalin® Lymphoma Drug 57

Premier Signs Contracts with Mallinckrodt, Agfa, Berlex 58

ADMD Announces Patent Licensing for Preparing Actinium-225 58

Bayer Schering Exercises Rights to License Avid's 18-F AV1/ZK

Compound 58

Covidien Signs Agreement with BioSynthema for Cancer Treatment

Technology 59

IBA Signs Contract to Supply Cyclone® 30 to Indian DAE 59

MDS Nordion, Ottawa University to Establish Molecular Imaging

Center of Excellence 59

Bracco, ImaRx Ink Cross Licensing Deal 60

GE Healthcare Signs Exclusive Distribution Deal with Draximage 60

DRAXIMAGE, Med Discovery Form Research Collaboration 60

Schering Changes Corporate Identity to Bayer Schering Pharma AG 60

IBA Establishes New Radiopharmaceuticals Production Facility 61

IBA Receives Approval for Production of Radiopharmaceuticals

at UK Facility 61

IBA Establishes Production and R&D Center in Belgium 61

MDS Nordion to Expand Medical Imaging Agent Production in Europe 61

MDS Nordion, Avid Radiopharmaceuticals Ink Collaborative

Agreement 62

MDS Nordion Establishes Centers of Excellence for TheraSphere®

in Europe 62

Peregrine Opens Facility in China 62

GE Healthcare Receives Approval for First Radiopharmacy

Facility in India 62

Peregrine Pharmaceuticals Launches Anti-Cancer Agent in China 63

GE Healthcare Introduces Proton Package For Radiation Therapy

Planning 63

GE Healthcare Expands Definium Series of Digital Radiographic

Products 63

7. MAJOR PLAYERS 64

Actinium Pharmaceuticals, Inc. (US) 64

Advanced Medical Isotope Corporation (US) 64

Alseres Pharmaceuticals, Inc (US) 64

Bayer HealthCare Pharmaceuticals (US) 64

Bio-Nucleonics, Inc. (US) 64

Bracco Diagnostics, Inc. (US) 65

Cardinal Health, Inc (US) 65

Cellectar, LLC. (US) 65

Cell Therapeutics, Inc. (US) 65

Covidien Imaging Solutions (US) 65

Cytogen Corporation (US) 66

Draximage Inc (Canada) 66

GE Healthcare Limited (UK) 66

GlaxoSmithKline Plc (UK) 66

IBA Molecular North America, Inc. (US) 67

Immunomedics, Inc. (US) 67

Kimberly-Clark, Inc. (US) 67

Lantheus Medical Imaging, Inc (US) 67

MDS Nordion (Canada) 68

Molecular Insight Pharmaceuticals, Inc. (US) 68

Peregrine Pharmaceuticals, Inc. (US) 68

PETNET Pharmaceuticals, Inc. (US) 68

Pharmalucence, Inc. (US) 69

Triad Isotopes, Inc. (US) 69

EXHIBITS

Table 1: Percentage Share Breakdown of Leading Medical

Diagnostics Imaging Manufacturer Value Sales in the World -

2003

Table 2: Percentage Revenue Market Shares of Leading

Radiopharmaceutical Medical Diagnostics Manufacturers in the

World - 2003

Table 3: Percentage Share Breakdown of Radioimmunotherapy

Products Manufacturer Value Sales in the World - 2003

Table 4: Breakdown of Diagnostic Radiopharmaceutical Agents

Procedure Volume by Imaging Procedure in the US - 2009

Table 5: Percentage Share Breakdown of Diagnostic

Radiopharmaceutical Agents in the US - 2012

Table 6: Percentage Share Breakdown of SPECT Myocardial

Perfusion Imaging (MPI) Procedure Volume by Imaging Agent in

the US - 2007

Table 7: Percentage Share Breakdown of Non-Cardiology

Diagnostic Radiopharmaceuticals Agent Manufacturer Value Sales

in the US - 2009

Table 8: Installed Base for SPECT and SPECT/CT Scanners in

Units in the North American Diagnostic Radiopharmaceutical

Market for Years 2008, 2010, 2012 & 2014

Table 9: Breakdown of FDG Procedure Volume by Procedure Type -

2009 (In 000s)

Table 10: US FDG Radiopharmacy Market: Number of Doses, Unit

Cost and Number of Nuclear Pharmacies for the Years 2008 &

    2012(P)

    Table 11: Percentage Share Breakdown of Leading Diagnostics

    Radiopharmaceuticals Agents Manufacturer Value Sales in the US -

    2007

    Table 12: Percentage Share Breakdown of Leading Cardiology

    Diagnostic Radiopharmaceutical Agents Manufacturer Value Sales

    in the US - 2007

    Table 13: Percentage Share Breakdown of Leading Non-Cardiology

    Diagnostic Radiopharmaceutical Agents Manufacturer Value Sales

    in the US - 2007

    Table 14: Percentage Share Breakdown of Therapeutic

    Radiopharmaceuticals Manufacturer Value Sales by Key

    Radiotherapeutics in the US - 2007

    Table 15: Percentage Share Breakdown of Leading Therapeutic

    Radiopharmaceutical Agents Manufacturer Value Sales in the US -

    2007

    Table 16: Percentage Share Breakdown of Leading FDG

    Manufacturers by Number of Cyclotrons Operated in the US -

    2007

    Table 17: Percentage Share Breakdown of Radiopharmaceutical

    Bone Palliation Procedures by Key Radiotherapeutics in the US -

    2005

    Table 18: Percentage Share Breakdown of Leading Diagnostics

    Radiopharmaceuticals Manufacturer Value Sales in the US - 2001

    Table 19: Percentage Share Breakdown of Leading Cardiology

    Diagnostics Radiopharmaceuticals Manufacturer Value Sales in

    the US - 2001

    Table 20: Percentage Share Breakdown of Leading Therapeutic

    Radiopharmaceuticals Manufacturer Value Sales in the US -

    2001

    Table 21: Percentage Share Breakdown of Leading

    Radiopharmaceuticals Manufacturer Value Sales by Diagnostic

    Procedures in the US - 2001

    Table 22: Percentage Breakdown of Radiopharmacy Market in the

    US - 2005

    Table 23: Percentage Share Breakdown of Leading

    Radiopharmacies Manufacturer Value Sales in the US - 2001

    Table 24: Radiopharmaceuticals Market by Segment in the US:

    2007-2015 (Sales in US$ Million)

    Table 25: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in the US for the Years 2009 & 2012

    Table 26: Percentage Share Breakdown of Diagnostic

    Radiopharmaceuticals by Imaging Modalities in Europe - 2008 &

    2012

    Table 27: Radiopharmaceuticals Market by Region in Europe:

    2007-2015 (Sales in US$ Million)

    Table 28: Percentage Breakdown of Radiopharmaceuticals Market

    by Region in Europe for the Years 2009 & 2012

    Table 29: Radiopharmaceuticals Market by Segment in Europe:

    2007-2015 (Sales in US$ Million)

    Table 30: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in Europe for the Years 2009 & 2012

    Table 31: Radiopharmaceuticals Market by Segment in France:

    2007-2015 (Sales in US$ Million)

    Table 32: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in France for the Years 2009 & 2012

    Table 33: Radiopharmaceuticals Market by Segment in Germany:

    2007-2015 (Sales in US$ Million)

    Table 34: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in Germany for the Years 2009 & 2012

    Table 35: Radiopharmaceuticals Market by Segment in Italy:

    2007-2015 (Sales in US$ Million)

    Table 36: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in Italy for the Years 2009 & 2012

    Table 37: Radiopharmaceuticals Market by Segment in the UK:

    2007-2015 (Sales in US$ Million)

    Table 38: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in the UK for the Years 2009 & 2012

    Table 39: Radiopharmaceuticals Market by Segment in Spain:

    2007-2015 (Sales in US$ Million)

    Table 40: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in Spain for the Years 2009 & 2012

    Table 41: Radiopharmaceuticals Market by Segment in Rest of

    Europe: 2007-2015 (Sales in US$ Million)

    Table 42: Percentage Breakdown of Radiopharmaceuticals Market

    by Segment in Rest of Europe for the Years 2009 & 2012

    COMPANIES PROFILED

    To order this report:

    Medical Equipment and Supply Industry: Radiopharmaceuticals - A US and European Market Analysis

    More Market Research Report

    
    Nicolas Bombourg
    Reportlinker
    Email: nbo@reportlinker.com
    US: (805)652-2626
    Intl: +1 805-652-2626
    
    

    SOURCE Reportlinker


    '/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved


Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2016)... , May 27, 2016 Amarantus ... focused on developing products for Regenerative Medicine, Neurology and Orphan Diseases, ... will be presenting at two upcoming investor conferences: ... 730 Third Avenue, New York City , NY ... Marcum MicroCap Conference   Where: Grand ...
(Date:5/26/2016)... 26, 2016 According to a new ... Market - U.S. Industry Analysis, Size, Share, Growth, Trends, and ... the U.S. was valued at US$ 5.89 Bn in 2014 ... from 2015 to 2023 to reach US$ 7.99 Bn in ... and emerging needle free drug delivery devices and the market ...
(Date:5/26/2016)... , May 26, 2016 ... With Both Cost Savings and Overall Decreased ... (LSE: BTG), an international specialist healthcare company, has ... the 21st Annual Meeting of ISPOR (International Society ... of hepatocellular carcinoma (HCC) using yttrium-90 glass microspheres ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed ... by inspiring human interest stories, courtesy of leaders in the nursing and health ... the industry, from leading advocates and associations—namely Jones & Bartlett Learning. , Jones ...
(Date:5/27/2016)... ... 27, 2016 , ... With a team of certified experts, ... Aside from its GMP accreditation, Validation Center is also a registered authority of ... and staff. , Validation Center is ISO17025 accredited and only offers its clients ...
(Date:5/26/2016)... ... May 26, 2016 , ... W.S. Badger Co. Inc ... honored with a 2016 When Work Works Award for its use of effective workplace ... national When Work Works project administered by the Families and Work Institute (FWI) and ...
(Date:5/26/2016)... ... May 26, 2016 , ... Georgia State University College of ... programs. , Answering to the increasing demand for curricular specializations, the Certificate in ... environmental and land use law. ,  , “The demand for lawyers with specific ...
(Date:5/26/2016)... Beach, Florida (PRWEB) , ... May 26, 2016 , ... ... Green House® Project offering a new model of care for living and healing, ... three core values: Meaningful Life in a Real Home provided by Empowered Staff. , ...
Breaking Medicine News(10 mins):